Overview

Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Status:
Completed

Trial end date:
2004-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the single-dose relative bioavailability study of 1 mg risperidone orally disintegrating tablets and (Risperdal M-TAB) under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Dr. Reddy's Laboratories Limited

Treatments:

Risperidone